1. Home
  2. CXM vs TNDM Comparison

CXM vs TNDM Comparison

Compare CXM & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$5.30

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

HOLD

Current Price

$15.27

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXM
TNDM
Founded
2009
2006
Country
United States
United States
Employees
N/A
2500
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
CXM
TNDM
Price
$5.30
$15.27
Analyst Decision
Hold
Buy
Analyst Count
8
19
Target Price
$8.28
★ $28.00
AVG Volume (30 Days)
★ 3.5M
1.7M
Earning Date
06-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.05
N/A
Revenue
$857,200,000.00
★ $1,014,736,000.00
Revenue This Year
$2.52
$8.11
Revenue Next Year
$4.94
$11.85
P/E Ratio
$108.60
★ N/A
Revenue Growth
7.64
★ 7.93
52 Week Low
$4.72
$11.46
52 Week High
$8.28
$29.65

Technical Indicators

Market Signals
Indicator
CXM
TNDM
Relative Strength Index (RSI) 37.12 35.01
Support Level $5.18 $14.44
Resistance Level $5.60 $16.50
Average True Range (ATR) 0.21 1.04
MACD -0.06 -0.22
Stochastic Oscillator 26.32 13.14

Price Performance

Historical Comparison
CXM
TNDM

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

Share on Social Networks: